The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital. The main question\[s\] it aims to answer are: * How much time and what resources are needed to run such a program * How well do patients follow up with the phone calls, bloodwork, and doctor appointments? * Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program? Participants will * Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital * Receive a phone call from the study team within 72 hours of discharge and weekly * Be given a follow up appointment with hepatology within 4 weeks of discharge Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
20
Intensive monitoring post discharge for cirrhosis and fluid overload
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
RECRUITINGfeasibility of the program
how much time does it take to review material and complete phone calls
Time frame: all 8 weeks of each participant
Number of instances of weight monitoring
at home monitoring weight
Time frame: 8 weeks for each participant
Number of successful phone calls
weekly phone call with participant
Time frame: 8 weeks for each participant
Number of follow up visits
lab visits, primary care visits, hepatology visits
Time frame: 8 weeks for each participant
Number of Hospitalizations per participant
number of admissions to the hospital
Time frame: 12 months
Number of subjects that develop Acute Kidney Injury
Creatinine increase of \>0.3g/dL
Time frame: 12 months
Number of subjects that continue to have volume overload
persistent weight above dry weight and/or ongoing ascites/lower extremity edema/pleural effusion
Time frame: 12 months
Number of subjects that expire
subject death
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.